European Liver Transplant Registry: Donor and transplant surgery aspects of 16,641 liver transplantations in children.


Journal

Hepatology (Baltimore, Md.)
ISSN: 1527-3350
Titre abrégé: Hepatology
Pays: United States
ID NLM: 8302946

Informations de publication

Date de publication:
03 2022
Historique:
revised: 12 09 2021
received: 26 01 2021
accepted: 16 10 2021
pubmed: 2 11 2021
medline: 4 3 2022
entrez: 1 11 2021
Statut: ppublish

Résumé

The European Liver Transplant Registry (ELTR) has collected data on liver transplant procedures performed in Europe since 1968. Over a 50-year period (1968-2017), clinical and laboratory data were collected from 133 transplant centers and analyzed retrospectively (16,641 liver transplants in 14,515 children). Data were analyzed according to three successive periods (A, before 2000; B, 2000-2009; and C, since 2010), studying donor and graft characteristics and graft outcome. The use of living donors steadily increased from A to C (A, n = 296 [7%]; B, n = 1131 [23%]; and C, n = 1985 [39%]; p = 0.0001). Overall, the 5-year graft survival rate has improved from 65% in group A to 75% in group B (p < 0.0001) and to 79% in group C (B versus C, p < 0.0001). Graft half-life was 31 years, overall; it was 41 years for children who survived the first year after transplant. The late annual graft loss rate in teenagers is higher than that in children aged <12 years and similar to that of young adults. No evidence for accelerated graft loss after age 18 years was found. Pediatric liver transplantation has reached a high efficacy as a cure or treatment for severe liver disease in infants and children. Grafts that survived the first year had a half-life similar to standard human half-life. Transplantation before or after puberty may be the pivot-point for lower long-term outcome in children. Further studies are necessary to revisit some old concepts regarding transplant benefit (survival time) for small children, the role of recipient pathophysiology versus graft aging, and risk at transition to adult age.

Sections du résumé

BACKGROUND AND AIMS
The European Liver Transplant Registry (ELTR) has collected data on liver transplant procedures performed in Europe since 1968.
APPROACH AND RESULTS
Over a 50-year period (1968-2017), clinical and laboratory data were collected from 133 transplant centers and analyzed retrospectively (16,641 liver transplants in 14,515 children). Data were analyzed according to three successive periods (A, before 2000; B, 2000-2009; and C, since 2010), studying donor and graft characteristics and graft outcome. The use of living donors steadily increased from A to C (A, n = 296 [7%]; B, n = 1131 [23%]; and C, n = 1985 [39%]; p = 0.0001). Overall, the 5-year graft survival rate has improved from 65% in group A to 75% in group B (p < 0.0001) and to 79% in group C (B versus C, p < 0.0001). Graft half-life was 31 years, overall; it was 41 years for children who survived the first year after transplant. The late annual graft loss rate in teenagers is higher than that in children aged <12 years and similar to that of young adults. No evidence for accelerated graft loss after age 18 years was found.
CONCLUSIONS
Pediatric liver transplantation has reached a high efficacy as a cure or treatment for severe liver disease in infants and children. Grafts that survived the first year had a half-life similar to standard human half-life. Transplantation before or after puberty may be the pivot-point for lower long-term outcome in children. Further studies are necessary to revisit some old concepts regarding transplant benefit (survival time) for small children, the role of recipient pathophysiology versus graft aging, and risk at transition to adult age.

Identifiants

pubmed: 34724224
doi: 10.1002/hep.32223
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

634-645

Commentaires et corrections

Type : CommentIn
Type : CommentIn
Type : CommentIn

Informations de copyright

© 2021 American Association for the Study of Liver Diseases.

Références

Starzl TE, Groth CG, Brettschneider L, Penn I, Fulginiti VA, Moon JB, et al. Orthotopic homotransplantation of the human liver. Ann Surg. 1968;168:392-415.
Angelico R, Nardi A, Adam R, Nadalin S, Polak WG, Karam V, et al. Outcomes of left split graft transplantation in Europe: report from the European Liver Transplant Registry. Transpl Int. 2018;31:739-50.
Elisofon SA, Magee JC, Ng VL, Horslen SP, Fioravanti V, Economides J, et al. Society of Pediatric Liver Transplantation: Current registry status 2011-2018. Pediatr Transplant. 2020; 24:e13605.
Bezinover D, Deacutis MF, Dalal PG, Moore RP, Stine JG, Wang M, et al. Perioperative thrombotic complications associated with pediatric liver transplantation: a UNOS database evaluation. HPB (Oxford). 2019;21:370-8.
Kasahara M, Umeshita K, Sakamoto S, Fukuda A, Furukawa H, Sakisaka S, et al. Living donor liver transplantation for biliary atresia: an analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society. Am J Transplant. 2018;18:659-68.
US Department of Health and Human Services. Scientific Registry of Transplant Recipients. Published 2018. https://SRTR.transplant.hrsa.gov/annual_reports/2018/Liver.aspx#LI_127_tx_ped_GF_DD_5yr_age_1_b64
Bowring MG, Massie AB, Chu NM, Bae S, Schwarz KB, Cameron AM, et al. Projected 20- and 30-year outcomes for pediatric liver transplant recipients in the United States. J Pediatr Gastroenterol Nutr. 2020;70:356-63.
Dharnidharka VR, Lamb KE, Zheng J, Schechtman KB, Meier-Kriesche HU. Across all solid organs, adolescent age recipients have worse transplant organ survival than younger age children: a US national registry analysis. Pediatr Transplant. 2015;19:471-6.
Ekong UD, Gupta NA, Urban R, Andrews WS. 20- to 25-year patient and graft survival following a single pediatric liver transplant-analysis of the United Network of Organ Sharing database: where to go from here. Pediatr Transplant. 2019;23:e13523.
Adam R, Karam V, Cailliez V, O’Grady JG, Mirza D, Cherqui D, et al. 2018 Annual report of the European Liver Transplant Registry (ELTR)-50-year evolution of liver transplantation. Transpl Int. 2018;31:1293-317.
Jean-St-Michel E, Kaufman M, Dipchand AI. Suboptimal survival for adolescent solid organ transplant recipients: a call to action? Pediatr Transplant. 2015;19:439-40.
Sagar N, Leithead JA, Lloyd C, Smith M, Gunson BK, Adams DH, et al. Pediatric liver transplant recipients who undergo transfer to the adult healthcare service have good long-term outcomes. Am J Transplant. 2015;15:1864-73.
McDiarmid SV, Davies DB, Edwards EB. Improved graft survival of pediatric liver recipients transplanted with pediatric-aged liver donors. Transplantation. 2000;70:1283-91.
Loirat C, Chalem Y, Golmard JL. Organ allocation in pediatric transplantation in France. Pediatr Nephrol. 2001;16:964-70.
Angelico R, Trapani S, Spada M, Colledan M, Ville de Goyet J, Salizzoni M, et al. A national mandatory-split liver policy: a report from the Italian experience. Am J Transplant. 2019 Jul;19:2029-43.
Valentino PL, Emre S, Geliang G, Li L, Deng Y, Mulligan D, et al. Frequency of whole-organ in lieu of split-liver transplantation over the last decade: children experienced increased wait time and death. Am J Transplant. 2019;19:3114-23.
Perito ER, Roll G, Dodge JL, Rhee S, Roberts JP. Split liver transplantation and pediatric waitlist mortality in the United States: potential for improvement. Transplantation. 2019;103:552-7.
McDiarmid SV, Anand R, Martz K, Millis MJ, Mazariegos G. A multivariate analysis of pre-, peri-, and post-transplant factors affecting outcome after pediatric liver transplantation. Ann Surg. 2011;254:145-54.
Englesbe MJ, Kelly B, Goss J, Fecteau A, Mitchell J, Andrews W, et al. Reducing pediatric liver transplant complications: a potential roadmap for transplant quality improvement initiatives within North America. Am J Transplant. 2012;12:2301-6.
Emond J. Reducing complications in pediatric liver transplantation: do we have the answer? Am J Transplant. 2012;12:2267-68.
Grimaldi C, di Francesco F, Chiusolo F, Angelico R, Monti L, Muiesan P, et al. Aggressive prevention and preemptive management of vascular complications after pediatric liver transplantation: a major impact on graft survival and long-term outcome. Pediatr Transplant. 2018;22:e13288.
Neto JS, Fonseca EA, Vincenzi R, Pugliese R, Benavides MR, Roda K, et al. Technical choices in pediatric living donor liver transplantation: the path to reduce vascular complications and improve survival. Liver Transpl. 2020;2:1644-51.

Auteurs

Jean de Ville de Goyet (J)

Department for the Treatment and Study of Pediatric Abdominal Diseases and Abdominal Transplantation, Istituto di Ricovero e Cura a Carattere Scientifico, Palermo, Italy.

Ulrich Baumann (U)

Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
Paediatric Gastroenterology and Hepatology, Hannover Medical School, Hannover, Germany.
European Liver and Intestine Transplant Association, Padua, Italy.

Vincent Karam (V)

European Liver Transplant Registry, Assistance Publique-Hôpitaux de Paris Hôpital Paul Brousse, Université Paris-Sud, Inserm U 935, Villejuif, France.

René Adam (R)

European Liver and Intestine Transplant Association, Padua, Italy.
European Liver Transplant Registry, Assistance Publique-Hôpitaux de Paris Hôpital Paul Brousse, Université Paris-Sud, Inserm U 935, Villejuif, France.

Silvio Nadalin (S)

Department of General, Visceral and Transplant Surgery, University Hospital Tübingen, Tübingen, Germany.

Nigel Heaton (N)

King's College Hospital, London, UK.

Raymond Reding (R)

Cliniques Universitaires Saint Luc, Université catholique de Louvain, Brussels, Belgium.

Sophie Branchereau (S)

Service de Chirurgie Viscérale Pédiatrique Bicêtre University Hospital, Faculty of Medicine Paris-Sud, Assistance Publique-Hôpitaux de Paris, Le Kremlin Bicêtre, France.

Darius Mirza (D)

Liver Unit, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.

Jürgen L Klempnauer (JL)

Klinik für Viszeral und Transplantations-chirurgie, Hannover Medical School, Hannover, Germany.

Lutz Fischer (L)

Department of Visceral Transplantation, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Piotr Kalicinski (P)

Department of Pediatric and Transplant Surgery, Children's Memorial Health Institute, Warsaw, Poland.

Michele Colledan (M)

Università degli studi di Milano Bicocca, ASST Giovanni XXIII, Department of Organ Failure and Transplantation, Bergamo, Italy.

Manuel Lopez Santamaria (M)

Pediatric Surgery Department, Hospital Infantil Universitario ''La Paz,", Madrid, Spain.

Ruben H de Kleine (RH)

Department of Surgery, Section of Hepato-Pancreatico-Biliary Surgery, University Medical Center Groningen, University of Groningen, Groningen, the Netherlands.

Christophe Chardot (C)

Service de Chirurgie Pediatrique, Hôpital Necker Enfants Malades, Paris, France.

Sezai Yilmaz (S)

Liver Transplantation Institute, Inonu University, Malatya, Turkey.

Murat Kilic (M)

Liver Transplant Program, Izmir Kent Hospital, Izmir, Turkey.

Olivier Boillot (O)

Pediatric Liver Transplant Surgery, Hôpital Edouard Herriot, Lyon, France.

Fabrizio di Francesco (F)

Department for the Treatment and Study of Pediatric Abdominal Diseases and Abdominal Transplantation, Istituto di Ricovero e Cura a Carattere Scientifico, Palermo, Italy.

Wojciech G Polak (WG)

European Liver and Intestine Transplant Association, Padua, Italy.
Erasmus MC, Transplant Institute, Division of Hepatopancreatobiliary and Transplant Surgery, Department of Surgery, University Medical Center Rotterdam, Rotterdam, the Netherlands.

Henkjan J Verkade (HJ)

European Liver and Intestine Transplant Association, Padua, Italy.
Department of Pediatrics, University Medical Center Groningen, University of Groningen, Hospital, Groningen, the Netherlands.
European Liver Transplant Registry, Assistance Publique-Hôpitaux de Paris Hôpital Paul Brousse, Université Paris-Sud, Inserm U 935, Villejuif, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH